Artificial intelligence-driven specific gut microbiome as a predictive biomarker for the therapeutic response to cancer immunotherapy in lung cancer- a multicenter prospective observational study
Not Applicable
Recruiting
- Conditions
- Advanced/recurrent lung cancer
- Registration Number
- JPRN-UMIN000046428
- Lead Sponsor
- ational Hospital Organization Kyushu Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients have already received cancer immunotherapy (2)Inadequate cases judged by doctors
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To establish the predictive system of therapeutic response to cancer immunotherapy using gut microbiome in lung cancer
- Secondary Outcome Measures
Name Time Method